Novel AT(1) receptor-independent functions of losartan

Circ Res. 2002 Apr 19;90(7):754-6. doi: 10.1161/01.res.0000016843.82450.8c.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Antihypertensive Agents / pharmacology*
  • Biotransformation
  • Cyclooxygenase 2
  • Humans
  • Imidazoline Receptors
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • Losartan / analogs & derivatives
  • Losartan / metabolism
  • Losartan / pharmacology*
  • Membrane Proteins
  • Myocardium / metabolism
  • Platelet Aggregation Inhibitors / metabolism
  • Platelet Aggregation Inhibitors / pharmacology
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Prostaglandins / metabolism
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin / metabolism*
  • Receptors, Drug / antagonists & inhibitors
  • Receptors, Tachykinin / antagonists & inhibitors
  • Receptors, Thromboxane / antagonists & inhibitors
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Angiotensin Receptor Antagonists
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Imidazoline Receptors
  • Isoenzymes
  • Membrane Proteins
  • Platelet Aggregation Inhibitors
  • Prostaglandins
  • Receptor, Angiotensin, Type 1
  • Receptors, Angiotensin
  • Receptors, Drug
  • Receptors, Tachykinin
  • Receptors, Thromboxane
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Losartan